Kala Bio (KALA) Accumulated Expenses (2016 - 2026)

At the end of FY2025, Kala Bio's Accumulated Expenses came in at $1.51 million, down 69.7% from FY2024.

• Annual Accumulated Expenses has declined for four consecutive years, with a five-year compound annual growth rate of -39.7% (FY2020 to FY2025).
• In prior years, Kala Bio's Accumulated Expenses was $4.98 million in FY2024 (-17.3%), $6.02 million in FY2023 (-32.5%), $8.91 million in FY2022 (-57.5%) and $20.99 million in FY2021 (+10.6%).
• The Q2 2026 figure stands as the lowest quarterly Accumulated Expenses in data going back to Q4 2016.
• On a year-over-year basis, Accumulated Expenses has declined in each of the last 15 quarters, with an average decline of 43.4% over the last eight quarters.
• The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2022, with growth of 40.2%; the weakest was Q2 2026, with a decline of 89.7%.
• According to Business Quant data, Accumulated Expenses for the three prior quarters was $513,000 (Q1 2026), $1.51 million (Q4 2025) and $2.83 million (Q3 2025).